Secondary Prevention and Health Promotion After Stroke
22. januar 2014 opdateret af: Ann-Cathrin Jonsson, Skane University Hospital
Secondary Prevention and Health Promotion After Stroke A Nurse-led Randomized Controlled Open Trial
The aim of this study was to examine to what extent a one year population of stroke patients at a university hospital had well regulated risk factors and health problems one year after stroke, and if a structured nurse-led previous follow-up in the intervention group including referrals if needed could influence health outcome and risk factors one year after stroke.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
The follow-up protocol was categorized into Risk factors, Patients' self-reports, and Other health problems.
Referral was sent to a physician if medical interventions were needed regarding risk factors measured above the limits as stated in the follow-up protocol in accordance with guidelines,and/or if any self-reported health problems were stated by the patients, or had been detected by the Specialist Nurse.
Primary outcome was comparison between the intervention group and control group at one year after stroke regarding proportion of regulated risk factors, and self-reports on health outcome.
Results of the two follow-ups of the intervention group were also compared.
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
597
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
-
Malmö, Sverige, 205 02
- Skåne University Hospital
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Barn
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
WHO criteria for definition of stroke Signed consent
Exclusion Criteria:
Other diagnosis causing neurological symptoms
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: Intervention group
Control of secondary prevention at three months and one year after stroke and referral to physician if medical interventions are needed.
Assessment of functional status and self-reports on health outcome.
Supportive counselling provided.
|
Patients' self-reports on Mobility, Self Care, Usual activities, Pain/Discomfort, Anxiety/Depression, Health Outcome were registered.
Health problems were assessed.
Secondary prevention was controlled by measuring blood pressure, Cholesterol levels, HbA1c, Weight to estimate nutritional status.
Functional status was assessed.
Supportive counselling was provided.
Referral was sent to physician if medical interventions were needed.
|
|
Andet: Control group
Standard care with no outlined follow-up until one year after stroke.
Control of secondary prevention after one year after stroke and referral to physician if medical interventions are needed.
Follow-up one year after stroke according to the same protocol as the intervention group.
|
No intervention three months after stroke.
Assessment one year after stroke and comparison with the intervention group.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Risk factors and health outcome compared between intervention group and control group
Tidsramme: Baseline to one year after stroke for both groups.
|
Outcome for both groups after one year was measured as the proportion of risk factors sufficiently treated, the patients' self-reports on health outcome and comparison between the intervention group and the control group.
|
Baseline to one year after stroke for both groups.
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Risk factors and health outcome at two follow-ups.
Tidsramme: Baseline to one year after stroke
|
Comparison of health outcome at three months and one year after stroke in the intervention group.
|
Baseline to one year after stroke
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Efterforskere
- Ledende efterforsker: Ann-Cathrin Jönsson, PhD, Department of Health Sciences, Lund University
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. februar 2008
Primær færdiggørelse (Faktiske)
1. februar 2010
Studieafslutning (Faktiske)
1. april 2010
Datoer for studieregistrering
Først indsendt
4. november 2011
Først indsendt, der opfyldte QC-kriterier
4. november 2011
Først opslået (Skøn)
8. november 2011
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
23. januar 2014
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
22. januar 2014
Sidst verificeret
1. januar 2014
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- MaStrokeFup0809
- UMASNL (Anden identifikator: Regional Ethical Review Board DNr 520/2007)
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .